Global Worker Confidence Plunges to Record Low Amid AI Job Displacement Fears
AI Agents for Email Sorting How Businesses Could Boost Productivity and Cut Costs
USChina Summit Yields Soybean and Rare Earth Deals Tariff Cut Discussions Continue
Vestas Wind Systems Stock Declines After Company Warns Margins Near Guidance Floor
US Benchmark Indices Hold Firm With Market Sentiment Remaining Upbeat
QLine Biotech IPO Allotment Expected Today Grey Market Premium at 115
PAGS Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Mixed Market Reaction
Weibo WB Q3 2025 Earnings EPS of 042 as Stock Edges Higher Amid Unclear Revenue Picture
RideNow Group Inc RDNW Q1 2026 Earnings SmallerThanExpected Loss Provides Modest Relief
FSS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
MGRX Q3 2025 Earnings Narrowing Losses as Strategic Pivot Gains Momentum
Ethos Technologies LIFE Q1 2026 Earnings Stellar EPS Surprise Fails to Lift Stock as Revenue Details Remain Elusive
Abeona Therapeutics ABEO Slips 145 as Stock Tests Key Support at 517
FG Merger II Corp FGMC Holds Near 1033 as SPAC Awaits Merger Catalyst
BJs Wholesale Club BJ Gains 26 as Retail Sector Finds Footing
Prairie Operating Co PROP Surges Over 9 as It Nears Key Resistance Level
Acco Brands ACCO Gains 25 as Stock Holds Above Key Support
European Reindustrialisation Faces Funding Challenge Amid AI Investment Surge
Cable One CABO Q1 2026 Earnings Earnings Beat Estimates Stock Surges 965
21Shares Dogecoin ETF TDOG Shows Cautious Pullback Amidst Crypto ETF Volatility
Amplitech Group Rights AMPGR Decline 781 as Stock Tests Key Support Levels
Rising Dragon Acquisition Corp RDAC Surges Nearly 10 as SPAC Shares Break Higher
Intellia Therapeutics NTLA Nears Key Support Amid Continued Downtrend
Trailblazer Acquisition Corp Unit BLZRU Holds Steady Near 1021 as Trading Activity Remains Subdued
Chegg Inc CHGG Surges 84 as Stock Bounces From Key Support Zone
Rani Therapeutics RANI Tests Key Resistance at 100 After Marginal Gain
Crinetics Pharmaceuticals CRNX Slips 152 as Biotech Sentiment Remains Cautious